Arcus Biosciences Inc (NYSE:RCUS)
| 18.23 Delayed Data As of Mar 31 |  +0.77 / +4.41%Today’s Change | 15.70 Today|||52-Week Range 39.75 | -11.85% Year-to-Date |
Latest RCUS News | Press Releases
No recent news for Arcus Biosciences Inc.
Today’s Trading
| Previous close | 17.46 |
| Today’s open | 17.77 |
| Day’s range | 17.77 - 18.50 |
| Volume | 957,754 |
| Average volume (3 months) | 1,177,925 |
| Market cap | $1.3B |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | -586.78% |
| Earnings growth (this year) | -25.87% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -70.75% |
| P/E ratio | NM |
| Price/Sales | 13.29 |
| Price/Book | 2.01 |
Competitors
| ---- | ||
| RCKTRocket Pharmaceutica... | +0.91 | +5.59% |
| IOVAIovance Biotherapeut... | -0.04 | -0.73% |
| DVAXDynavax Technologies... | +0.16 | +1.66% |
Data as of 4:00pm ET, 03/31/2023
Financials
| Next reporting date | May 8, 2023 |
| EPS forecast (this quarter) | -$1.16 |
| Annual revenue (last year) | $112.0M |
| Annual profit (last year) | -$267.0M |
| Net profit margin | -238.39% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Hayward, California |
Forecasts
